Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •1.1.4 Components of niosome
- •1.1.5 Factors affecting niosomes
- •Preface
- •Abstract
- •1.1 Introduction
- •1.1.1 Why niosome?
- •1.1.2 Advantages of niosome
- •1.1.3 Structure of niosome
- •1.2 Applications of niosome
- •1.2.2 Niosomes for the delivery of therapeutics
- •1.2.3 Niosomes in biomedical applications
- •1.3 Conclusions and future prospects
- •Keywords
- •References
- •Abstract
- •2.1 Introduction
- •2.2 Conclusions
- •Acknowledgments
- •Keywords
- •References
- •Abstract
- •3.1 Introduction
- •3.2.1 Parameters involved in electrospinning process
- •3.2.2 Biomaterials for electrospinning
- •3.3 Electrospun nanofibers as drug delivery systems
- •3.3.1 Blending electrospinning
- •3.3.2 Emulsion electrospinning
- •3.3.3 Coaxial electrospinning
- •3.3.4 Surface modifications
- •3.4 Electrospun nanofibers for tissue engineering
- •3.4.1 Electrospun nanofibers for hard tissue engineering
- •3.5 Cancer diagnosis and therapy
- •3.6 Concluding remarks and future perspectives
- •Keywords
- •References
- •4. Natural Biocarriers for Brain Targeting
- •Abstract
- •4.1 Introduction
- •4.1.1 Central nervous system
- •4.2 Biocarriers
- •4.2.1 Carbohydrates carriers
- •4.2.2 Protein carriers
- •4.2.3 Exosomes
- •4.3 Conclusions and perspectives
- •Keywords
- •References
- •Abstract
- •5.1 Introduction
- •5.2 Synthesis of graphene family nanomaterials
- •5.2.1 Graphene synthesis
- •5.2.2 GO and rGO Syntheses
- •5.2.3 GQd synthesis
- •5.4 Drug delivery and biomedical applications
- •5.4.1 Drug delivery
- •5.4.2 Gene delivery
- •5.4.3 Bioimaging
- •5.4.4 Photothermal therapy
- •5.4.5 Tissue engineering
- •5.5 Summary and future prospect
- •Keywords
- •References
- •6. Nanotechnology in Gene Delivery
- •Abstract
- •6.1 Introduction
- •6.2 Gene delivery
- •6.3 Nanotechnology in gene delivery
- •Keywords
- •References
- •Abstract
- •7.1 Introduction
- •7.2 Additive manufacturing in pharmacology
- •7.2.1 Extrusion-based 3D printing techniques
- •7.2.2 Stereolithography
- •7.2.3 Selective laser sintering
- •7.2.4 Binder jet printing
- •7.3 Most common polymers
- •7.3.1 Natural polymers
- •7.3.2 Synthetic polymers
- •7.3.2.5 Polyvinylpyrrolidone
- •7.4 Common 3D-printed dosage forms
- •7.4.1 Scaffolds
- •7.4.2 Tablets
- •Keywords
- •References
- •7.4.3 Microneedles
- •7.4.4 Capsule
- •7.4.5 Films
- •7.5 Main factors in drug delivery
- •7.5.1 Nature of polymers
- •7.5.2 Matrix permeability
- •7.5.3 Polymer blends
- •7.5.4 Specific surface area
- •7.5.5 Infill density and patterns
- •7.5.6 Pores
- •7.5.7 Cross-linking
- •7.5.8 Coating
- •7.5.9 Core/shell and multicompartment
- •7.6 Final considerations and future perspectives
- •Abstract
- •8.1 Introduction
- •8.2.1 Polymer solution concentration and viscosity
- •8.2.2 Molecular weight of polymer
- •8.2.3 Surface tension
- •8.2.4 Electrical conductivity
- •8.2.5 Applied voltage
- •8.2.6 Feed rate/flow rate
- •8.2.7 Temperature and humidity
- •8.3 Method of preparation for nanofibers
- •8.3.1 Electrospinning
- •8.3.2 Self-assembly
- •8.3.3 Phase separation
- •8.3.4 Drawing of nanofibers
- •8.3.5 Template synthesis
- •8.4 Biomedical applications of nanofibers
- •8.4.1 Wound dressing
- •8.4.2 Tissue engineering
- •8.4.3 In cancer therapy
- •8.4.4 Miscellaneous
- •8.5 Drug delivery application
- •8.5.1 Antihypertensive drug
- •8.5.2 Antimicrobial drug
- •8.5.3 Growth hormone
- •8.5.4 Miscellaneous
- •8.6 Conclusion
- •Keywords
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Tissue engineering
- •9.3 Nanotechnology
- •9.4 Polymeric scaffolds in tissue engineering
- •9.5 Challenges
- •Keywords
- •References
- •Abstract
- •10.1 Introduction
- •10.2 Ideal properties of bioceramics
- •10.2.1 Mechanical property
- •10.2.2 Porosity, pore size, and shape
- •10.2.3 Biocompatibility and biodegradability
- •10.2.4 Osteoconductivity and osseointegrity
- •10.3 Bioceramics in orthopedic applications
- •10.4 Bioceramics in maxillofacial surgery
- •10.5 Bioceramic in drug delivery applications
- •10.6 Doped bioceramic in biomedical application
- •10.7 Conclusions
- •10.8 Future direction
- •Acknowledgments
- •Keywords
- •References
- •Index

318
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
J.
Oral Maxillofac. Surg. 2002, 60,
Nanobiomaterials in Clinical
Dentistry (Second Edition), Micro and Nano Technologies
Materials 2017, 10, 334.
Oral
Maxillofac. Surg. Clin. 2017, 29,
J. Biomater. Appl. 2020, 35,
Biosens. Bioelectron. 2014, 57,
J. Oral
Maxillofac. Surg. 2005, 63,
Engineering. Materials 2018, 11,
ceramic Micro-laminates. Acta Mater. 2018, 144,
actamat.2017.10.059
Small 2011, 7,
vivo. Acta Biomater. 2013, 9,
J. Am. Chem. Soc. 1997, 119,
Regeneration. Odontology 2017, 105,
tissue Engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 2014, 43,
Mesostructured Silicas: A Novel Approach to Reduce the SiO2 Leaching in Water. Chem.
Mater. 2009, 21,

Bioceramics System for Biomedical Application
319
Acta Biomater. 2011, 7,
Reconstruction. ACS Biomater. Sci. Eng. 2018, 4,
acsbiomaterials.8b00521
Bone Substitutes: An Update
27-28 November 2004 36,
2009, 40,
Drug Delivery System. ACS Appl. Mater. Interfaces 2014, 6,
Mater. Sci. Eng. C 2015, 47,
Curr. Pharm.
Biotechnol. 2017, 18, 95–106.
J. Cranio-
Maxillofac. Surg. 2018, 46,
Int. J. Oral Maxillofac. Implants 2012, 27,
288–294.
Morphologie, Special Issue: Beta-tricalcium Phosphate: From the Laboratory to Surgical
Practice 2017, 101,
Habibovic, P. Strategic Directions in Osteoinduction and Biomimetics. Tissue Eng. Part A
2017, 23,
Biomaterials 2005, 26,
Today 2016, 19,
An Introduction To Bioceramics
Science 1984, 226,
Dev. Comp.
Immunol. 2020, 104,

320
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Implants 2012, 27, 352–358.
Complex. Cells Mater. 1992, 2.
silver Vanadate as a Promising Antibacterial Additive to Water-based Paints. Nanomed.
Nanotechnol. Biol. Med. 2012, 8,
in Ordered Mesoporous Materials. Solid State Sci. 2004, 6,
Bone Regeneration. InAdvances in Dental Implantology Using Nanomaterials and Allied
Technology Applications
Application: Calcium Phosphate, Calcium Sulphate and Calcium Silicate. Adv. Appl.
Ceram. 2015, 114,
Strategy. Mater . Sci. Eng. C 2020, 109,
Key Eng. Mater. 2008, 377, 133–150.
Eur. J. Pharm. Sci.
2005a, 26,
Solid State Sci. 2005b,
7,
Int. J. Appl. Glass Sci. 2016, 7,
J. Int. Dent. Med. Res. 2016, 9, 427–435.
J. Phys. Chem. B 2002, 106,
Surgery in Europe. J. Cranio-Maxillofac. Surg. 2014, 42,
Biomaterials 2005, 26,

Bioceramics System for Biomedical Application
321
J. Craniofac. Surg. 2016, 27,
Mater. Sci. Eng. C 2017, 71, 604–610.
J. Taiwan Inst. Chem. Eng. 2016, 60,
Dent. Hypotheses 2020, 11,
Fractures Using Bioactive Glass. J. Cranio-Maxillofac. Surg. 2000, 28,
J. Craniofac. Surg. 2014, 25, 1062–1067.
J. Cranio-Maxillofac. Surg. 2010, 38,
Nature 1992a,
359,
Nature 1992b,
359,
J. Phys. Chem. B 2000, 104,
AIP Conf. Proc. 2020, 2310,
based Composites. Acta Mater. 2013, 61,
actamat.2013.05.013
Int. J. Appl. Eng. Res. 2018, 13, 2744–52.
Ordered Mesoporous Silicas. Curr. Pharm. Des. 2015, 21, 6213–6819.

322
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
J. Mech. Behav. Biomed. Mater. 2019, 91,
Science 1993, 260,
Hierarchical Complexity. Acta Mater. 2009, 57,
actamat.2009.03.003
J. Eur. Ceram. Soc. 1995, 15,
Mol. Phys. 2006, 104, 1635–1641.
J. Orthop. Trauma
2015, 29,
Clin.
Orthop. 2002,
Mesoporous Materials: Controlling the Entrance to Nanospace. Microporous Mesoporous
Mater. 2004, 73,
Bioactive Glass Nanoparticles in Osteogenic Commitment. ACS Appl. Mater. Interfaces
2018, 10,
Biomater. Focus Biomater. Sci.
Asia 2003, 24,
Sci. Rep. 2017, 7,
Macromol. Rapid Commun. 2021, 42,
Dent. Mater. 2019, 35,
Mitochondria. ACS Appl. Mater. Interfaces 2017, 9,
acsami.7b06906
Nanomedicine Nanotechnol. Biol. Med. 2012, 8,
nano.2011.06.002

Bioceramics System for Biomedical Application
323
Small 2010, 6,
Chem. Eng. J. 2018, 340, 1–1.
Stomatologiia (Sofiia)
2008, 87, 22–26.
Chem. Eng. J.; Porous Inorganic Mater.
Biomed. Appl. 2008, 137,
Exp. Opin. Drug Deliv. 2009, 6,
Acta Biomater. 2011, 7,
Delivery Systems. Prog. Solid State Chem. 2012a, 40,
progsolidstchem.2012.05.001
Delivery Systems. Prog. Solid State Chem. 2012b, 40,
progsolidstchem.2012.05.001
Drug Delivery. J. Mater. Chem. 2010, 20,
Tissue Eng. 2007, 13,
Chem. Commun. 2013, 49,
Nanoscale 2017, 9, 15967–15973.
RSC
Adv. 2016, 6,
Monolithic Versus Manually Veneered All-ceramic Systems. Int. J. Oral Maxillofac.
Implants 2012, 27, 1448–1455.
Materials 2014, 7,

324
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Tanta Dent. J.
2015, 12,
Nano. Lett. 2012, 12, 3417–
Agent. Colloids Surf. B Biointerfaces 2014, 116,
Int. J. Oral Maxillofac. Surg. 2007, 36,
Reverse Engineering
Approach for Customized Dental and Maxillofacial Implants of Alumina Fibre Reinforced
Composite
2019
Dent. Clin. 2020, 64,
J. Clin. Med. 2021, 10,
Chem. Mater. 2003, 15,
Mesenchymal Stem Cells. J. Med. Life 2020, 13,
Res. Vet. Sci. 2009, 86, 162–173.
In Biomaterials and Medical Devices: A Perspective from an Emerging Country, Advanced
Structured Materials
J. Dent. 2022, 121,
Augmentation. J. Orthop. Trauma 2015, 29

Bioceramics System for Biomedical Application
325
Nanomaterials 2019, 9,
Bioact. Mater.
2019, 4,
SBA-15 as Key Factor to Modulate Sodium Alendronate Dosage. Micr opor ous Mesoporous
Mater. 2008, 116,
Ceram. Int. 2020, 46, 4058–4064.
J. Periodontal Res. 2016, 51,
J. Biomed. Mater. Res. A 2009,
91,
Environ. Health Rep. 2015, 2,
Options, Novel Strategies, and Future Directions. J. Orthop. Surg. 2014, 9,
Ceram. Int. 2021, 47,
ceramint.2021.07.100
J. Mater. Sci.
2017, 52,
Am. Mineral. 2016, 101,
In Bioactive Glasses, Woodhead Publishing Series in Biomaterials
J. Nanomater. 2015, 2015,
J. Non-Cryst. Solids 2017, 455,

326
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
World
Neurosurg. 2015, 83,
BioMed Res. Int. 2013, 2013,
Craniomaxillofacial
Trauma Reconstr. 2016, 9,
J. Reparative Reconstr. Surg. 2014, 28, 286–291.
Microporous
Mesoporous Mater. 2006, 92,
J. Mater. Res. Technol. 2018, 7,
Prog. Biomater. 2019, 8,
J. Int. Oral Health JIOH
2015, 7, 138–142.
Langmuir 2002a, 18,
Langmuir 2002b, 18,
Material. J. Am. Coll. Surg., Surgical Forum Abstracts 2013, 217,
Biomaterials 2006,
27,
Mater. Sci. Eng. C 2018,
90,
ACS Nano. 2009, 3,

Bioceramics System for Biomedical Application
327
Drug-Delivery V ectors. Small 2010, 6,
Osteogenesis and Angiogenesis both In V itro and In vivo. Biomaterials 2019, 197, 405–416.
J. Phys. Chem. 1996, 100,
World J. Clin. Cases WJCC 2015, 3,
Aggregate as a Root-end Filling. J. Endod. 2008, 34,
Concerning the Most Cited Metal Ions Doped Bioceramics and Silicate-based Bioactive
Ceram. Int. 2021, 47,
2. Orv. Hetil. 2012, 153,
J. Mater.
Sci. Mater. Med. 2013, 24,
Silicon 2018, 10, 1171–1179.
Ceram. Int. 2019, 45,
ceramint.2019.02.067
Microplatelets as Next-Generation Antibacterial Orthopedic Biomaterials. J. Biomed.
Mater. Res. B Appl. Biomater. 2020, 108,
J. Drug Deliv. Sci.
Technol. 2020, 55,
Dentistry. Int. J. Mol. Sci. 2019, 20,
J. Am.
Chem. Soc. 2006, 128,
Соседние файлы в папке Библиотека им академика М.И. Перельмана
